The drug development pipeline for glioblastoma-A cross sectional assessment of the FDA Orphan Drug Product designation database.
<h4>Background</h4>Glioblastoma (GBM) is the most common malignant brain tumour among adult patients and represents an almost universally fatal disease. Novel therapies for GBM are being developed under the orphan drug legislation and the knowledge on the molecular makeup of this disease...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Public Library of Science (PLoS)
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/5915c13d95864035a72fc359f140445e |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|